Approval of new biopharmaceuticals 1999–2006: Comparison of the US, EU and Japan situations

Kaori Tsuji1,2, Kiichiro Tsutani1
1Drug Policy and Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan
2The Health Care Science Institute, Tokyo, Japan